Medicine Marrow Pg No 805-814 (Nephrology)
53 Questions
0 Views

Medicine Marrow Pg No 805-814 (Nephrology)

Created by
@PremierMetaphor

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is osteitis fibrosa cystica primarily associated with?

  • Increased phosphate levels (correct)
  • High calcium levels
  • Adynamic bone disease
  • Decreased GFR

    • Secondary hyperparathyroidism is characterized by hypocalcemia and hypophosphatemia.

    False

    What enzyme's inhibition leads to calcitriol deficiency in patients with CKD?

    1,25-dihydroxyvitamin D 1-alpha-hydroxylase (1,2 hydroxylase)

    In chronic kidney disease, the glomerular filtration rate (GFR) tends to _____ significantly.

    <p>decrease</p> Signup and view all the answers

    Match the following conditions with their definitions:

    <p>Osteitis fibrosa cystica = Condition caused by increased phosphate levels Adynamic bone disease = Lower bone turnover often in elderly women with diabetes Left ventricular hypertrophy = Heart condition related to CKD Secondary Hyperparathyroidism = Increased parathyroid activity in response to hypocalcemia</p> Signup and view all the answers

    What is the most common cause of anemia in chronic kidney disease?

    <p>Decreased RBC production</p> Signup and view all the answers

    In chronic kidney disease, elevated levels of erythropoietin (EPO) contribute to anemia.

    <p>False</p> Signup and view all the answers

    What effect does hypoxia have on erythropoietin production?

    <p>It triggers the activation of Hypoxia-Inducible Factor-alpha (HIF-α), leading to reduced EPO production.</p> Signup and view all the answers

    Chronic inflammation stimulates the production of __________, which contributes to anemia.

    <p>hepcidin</p> Signup and view all the answers

    Match the following complications of anemia in chronic kidney disease with their consequences:

    <p>Left Ventricular Hypertrophy (LVH) = Increased cardiovascular mortality Calcification = Impaired blood vessel function Endothelial Dysfunction = Increased risk of cardiovascular events Uremic Toxins = Inhibition of erythropoiesis</p> Signup and view all the answers

    What is the primary consequence of a decrease in the number of viable nephrons in chronic kidney disease?

    <p>Intraglomerular hypertension and proteinuria</p> Signup and view all the answers

    Viable nephrons can be regenerated or replaced after birth.

    <p>False</p> Signup and view all the answers

    What is the most common cause of chronic kidney disease?

    <p>Diabetic Kidney Disease (DKD)</p> Signup and view all the answers

    The primary determinant of renal function decline in chronic kidney disease is the __________.

    <p>tubulointerstitium</p> Signup and view all the answers

    Match the following conditions with their descriptions:

    <p>Diabetic Kidney Disease = Most common cause of chronic kidney disease Chronic Glomerulonephritis = Damage to the glomeruli Ischemic nephropathy = Reduced blood flow to the kidneys Adult polycystic kidney disease = Genetic condition causing cysts in kidneys</p> Signup and view all the answers

    Which of the following iron therapies is administered intravenously?

    <p>Both B and C</p> Signup and view all the answers

    EPO-α has a half-life of 8.5 hours.

    <p>True</p> Signup and view all the answers

    What is the prerequisite to start EPO therapy in terms of TSAT?

    <p>TSAT ≥30%</p> Signup and view all the answers

    Daprodustat is classified as a _______ hydroxylase inhibitor.

    <p>prolyl</p> Signup and view all the answers

    Match the drugs with their characteristics:

    <p>EPO-β (CERA) = 0.6 µg/kg weekly Darbepoetin = 60-200 µg/2 weekly Daprodustat = Prolyl hydroxylase inhibitor EPO-α = T1/2: 8.5 hrs</p> Signup and view all the answers

    What can cause anemia in patients with chronic kidney disease?

    <p>Decreased Glomerular Filtration Rate (GFR)</p> Signup and view all the answers

    Anemia can develop independently of changes in the Glomerular Filtration Rate (GFR) in chronic kidney disease.

    <p>False</p> Signup and view all the answers

    What is the primary condition that leads to anemia in chronic kidney disease?

    <p>Decreased Glomerular Filtration Rate (GFR)</p> Signup and view all the answers

    Anemia appears in chronic kidney disease when the Glomerular Filtration Rate (GFR) __________.

    <p>decreases</p> Signup and view all the answers

    Match the following terms related to chronic kidney disease with their correct descriptions:

    <p>Anemia = A condition often resulting from decreased GFR Glomerular Filtration Rate (GFR) = A measure of kidney function Chronic Kidney Disease = Long-term impairment of kidney function Erythropoietin = Hormone that stimulates red blood cell production</p> Signup and view all the answers

    What is the leading cause of mortality in ESRD patients?

    <p>Cardiac causes</p> Signup and view all the answers

    Younger patients with CKD have a significantly lower risk of cardiac disease compared to the control population.

    <p>False</p> Signup and view all the answers

    What is the best marker for myocardial infarction in CKD patients?

    <p>Trop-1</p> Signup and view all the answers

    In CKD, preserved ejection fraction (EF) is often associated with _________.

    <p>heart failure</p> Signup and view all the answers

    Match the conditions with their corresponding features in CKD:

    <p>Uremic Cardiomyopathy = Causes pericarditis and arrhythmias Left Ventricular Hypertrophy (LVH) = Enlargement of the heart's left ventricle Medial Calcification = Calcium deposits in arteries Dysbiosis = Disruption of gut microbiota</p> Signup and view all the answers

    Which of the following is a clinical feature of Calciphylaxis?

    <p>Violaceous painful plaque</p> Signup and view all the answers

    Patients with CKD should strictly avoid calcium and Vitamin D supplements.

    <p>False</p> Signup and view all the answers

    What is the primary cause of Nephrogenic Systemic Fibrosis?

    <p>Gadolinium-based contrast</p> Signup and view all the answers

    In the case of Calciphylaxis, the arterioles undergo medial __________ due to vasculopathy.

    <p>calcification</p> Signup and view all the answers

    Match the body part with its corresponding image description related to Calciphylaxis:

    <p>Leg = Image A Buttocks = Image B Abdomen = Image C Thigh = Image D</p> Signup and view all the answers

    Which of the following is NOT an indication for dialysis?

    <p>Severe headache</p> Signup and view all the answers

    A holistic approach to CKD treatment should include the use of tobacco products.

    <p>False</p> Signup and view all the answers

    What is the target LDL level for patients with diabetic CKD?

    <p>70 mg/dL</p> Signup and view all the answers

    The first-line drug therapy for managing proteinuria includes ACE(-) or ARBS and _____ for most patients.

    <p>SGLT2</p> Signup and view all the answers

    Match the following components with their respective descriptions:

    <p>AV fistula = Access creation for dialysis Finerenone = 2nd line drug therapy for proteinuria Uremia symptoms = Definitive indication for dialysis Salt restriction = Lifestyle modification for CKD</p> Signup and view all the answers

    What could be a hurdle for a patient fit for transplantation?

    <p>Medial calcifications</p> Signup and view all the answers

    The mortality rates after the initiation of dialysis decrease over time.

    <p>False</p> Signup and view all the answers

    What is the main reason for creating an AV fistula before dialysis treatment?

    <p>To allow for adequate access for dialysis</p> Signup and view all the answers

    What is the GFR range for Stage G3a in kidney classification?

    <p>45 - 59 ml/min</p> Signup and view all the answers

    Cardiac complications are the most common cause of death in kidney disease.

    <p>True</p> Signup and view all the answers

    List two reversible causes of kidney dysfunction.

    <p>Obstruction, Uncontrolled hypertension</p> Signup and view all the answers

    Stage G4 of kidney classification corresponds to a GFR of _____ ml/min.

    <p>15 - 29</p> Signup and view all the answers

    Match the following complications with their characteristics:

    <p>Anemia = Low red blood cell count Acidosis = Excess acid in the body Bone Mineral Disease = Renal osteodystrophy Electrolyte imbalance = Disruption of essential minerals</p> Signup and view all the answers

    Which of the following is a first-line treatment for high bone turnover in CKD?

    <p>Sevelamer Carbonate</p> Signup and view all the answers

    Pure phosphate binders can lead to decreased LDL levels.

    <p>True</p> Signup and view all the answers

    What is the target calcium level in CKD management?

    <p>&lt; 9.5</p> Signup and view all the answers

    In chronic kidney disease, the normal range for PTH is __________ pg/ml.

    <p>50-100</p> Signup and view all the answers

    Match the following treatments with their related features:

    <p>Sevelamer Carbonate = Lowers LDL levels Ferric citrate = Phosphate binder Calcitriol = Vitamin D treatment Calcium phosphate binders = Used in significant hypocalcemia</p> Signup and view all the answers

    Study Notes

    Anemia in Chronic Kidney Disease

    • Anemia is a common complication of chronic kidney disease (CKD) and can be caused by decreased red blood cell (RBC) production or decreased RBC survival.
    • Decreased RBC production is more common and is due to low iron levels, poor iron absorption, and blood loss.
    • Decreased RBC survival is less common and is due to increased RBC destruction or reduced red blood cell lifespan.

    Hypoxia-Inducible Factor (HIF)-alpha

    • Hypoxia (low oxygen) triggers the activation of HIF-alpha.
    • HIF-alpha stimulates erythropoietin (EPO) production in the kidneys, leading to increased RBC production.
    • In CKD, the kidneys are damaged and lose their ability to produce EPO, leading to anemia.
    • Inflammation and other factors contribute to anemia in CKD.

    Iron Therapy

    • Iron therapy is the first step in managing anemia in CKD.
    • Iron deficiency is the most common cause of ESA hyporesponsiveness.
    • Formulas are available to determine iron requirements.
    • Oral iron supplements are less effective than intravenous iron therapy.
    • Intravenous iron therapy is preferred for patients with significant iron deficiency.

    EPO Stimulating Agents (ESA)

    • ESA are used to stimulate red blood cell production.
    • ESA are only given to patients with adequate iron stores.
    • EPO-alpha and EPO-beta are commonly used ESA.
    • Darbepoetin is a long-acting EPO-beta that may increase the hematocrit more effectively than EPO-alpha.
    • Daprodustat is prolyl hydroxylase inhibitor which may be a future alternative to ESA.

    Chronic Kidney Disease (CKD)

    • CKD is a progressive disease that leads to a decline in glomerular filtration rate (GFR).
    • The number of viable nephrons declines in CKD, which causes intraglomerular hypertension and proteinuria.
    • GFR can be calculated using different methods:
      • Cockcroft-Gault formula
      • MDRD equation
      • CKD-EPI equation

    Management of CKD

    • Lifestyle modifications are essential for managing CKD.
    • Medications can be used to manage proteinuria, hypertension, and other complications.
    • Dialysis may be needed for patients with advanced CKD.
    • Kidney transplantation may be an option for some patients.

    CKD - Mineral Bone Disease

    • CKD-MBD is a complex disorder that affects bone metabolism.
    • High bone turnover is characterized by osteitis fibrosa cystica.
    • Low bone turnover is characterized by adynamic bone disease.
    • Calcification is a common complication of CKD-MBD.
    • Treatment of CKD-MBD involves managing phosphate levels, calcium levels, and vitamin D levels.
    • Phosphate binders are the first-line treatment for hyperphosphatemia.
    • Calcitriol is a vitamin D analogue that can be used to treat hypocalcemia and hyperparathyroidism.
    • Bisphosphonates can be used to treat low bone mass.
    • Calcium and vitamin D supplements should be used with caution in CKD patients.

    CKD - Cardiovascular System

    • Cardiovascular disease is a major cause of death in CKD patients.
    • CKD patients have an increased risk of heart disease and hypertension.
    • Uremic toxins contribute to cardiovascular disease in CKD.
    • Early diagnosis and treatment of cardiovascular disease are essential in CKD patients.
    • Pre-transplant evaluation for vascular calcification is mandatory.

    Telegram channel - @back_ed8

    • The Telegram channel @back_ed8 contains more information on nephrology.

    Nephrology

    • This appears to be the label or a reference to a specific section within the document.

    Rate of Fall of GFR (ml/min/year)

    • The rate of decline in GFR varies depending on the underlying cause of CKD.
    • DKD (Diabetic Kidney Disease) is the most common cause with a rapid rate of decline in GFR.
    • CGN (Chronic Glomerulonephritis) has a moderate rate of decline in GFR.
    • IN (Ischemic Nephropathy) has a slower rate of decline in GFR.
    • CTID (Chronic Tubulointerstitial Disease) has the slowest rate of decline in GFR.

    Classification (GFR)

    • The stages of CKD are classified based on GFR.
    • Stage 1 is characterized by GFR > 90 ml/min.
    • Stage 5 is characterized by GFR <15 ml/min or end-stage renal disease (ESRD).

    Complications (Mnemonic: ABCDE)

    • Common complications of CKD:
      • Anemia
      • Acidosis
      • Access for dialysis
      • Bone mineral disease
      • Cardiac complications
      • Dry weight
      • Electrolyte imbalances
      • Uremia

    Management

    • Diagnosis of CKD is based on:
      • Presence of kidney damage
      • Decreased GFR
      • History of CKD
    • Treatment:
      • Address reversible causes.
      • Manage complications.
      • Monitor GFR.

    CKD - Calciphylaxis & Cardiovascular Changes

    • Calciphylaxis is a rare but serious complication of CKD.

    • It is characterized by painful, ischemic necrosis of the skin and subcutaneous fat.

    • The pathogenesis of calciphylaxis is complex and involves hyperphosphatemia, vitamin K deficiency, and vascular calcification.

    • It is associated with a high mortality rate.

    • Treatment usually involves supportive care, wound care, and treatment of hyperphosphatemia.

    • The document lists specific figures and tables.

    • The document is a protocol or treatment guide for chronic kidney disease (CKD).

    • Some of the tables and graphs are related to dialysis, particularly the "Total Glomerular Filtration Rate (GFR)" and "Plasma Concentration" graphs.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz explores the relationship between anemia and chronic kidney disease (CKD), including causes, mechanisms, and management strategies. It highlights the role of iron therapy and hypoxia-inducible factors in erythropoiesis. Test your knowledge on how to address anemia in CKD patients effectively.

    More Like This

    Anemia and Its Management
    43 questions

    Anemia and Its Management

    FreedRhyme avatar
    FreedRhyme
    Anemia Nursing Care Management Flashcards
    16 questions

    Anemia Nursing Care Management Flashcards

    CompliantMemphis avatar
    CompliantMemphis
    Introduction to Anemia Blood Loss
    18 questions

    Introduction to Anemia Blood Loss

    LuminousGadolinium avatar
    LuminousGadolinium
    Classification of Anemia Flashcards
    28 questions

    Classification of Anemia Flashcards

    GlisteningRadon avatar
    GlisteningRadon
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser